For Press Officers
Q: Am I allowed access to the JAMA Media Center?
Press officers affiliated with professional associations (i.e., American Academy of Pediatrics and American Heart Association), hospitals, academic institutions, and medical centers are allowed access.
Press officers employed by industry (i.e., pharmaceutical companies and device manufacturers), websites publishing sponsored content for industry, or and PR firms or freelance PR professionals representing industry as clients are not provided access
Q: I’m a new Press Officer. How do I hear about new JAMA and JAMA Network studies?
You should apply for access to the JAMA Media Center.
Sign up for access to the JAMA Media Center by creating an account. Once your account has been created you will receive an email with a link to apply for access. A member of the JAMA Media Relations team will review your application.
If you already have an account but need to update your email address, do so here.
If you have questions about your account, email mediarelations@jamanetwork.org.
Q: Am I allowed to post a news release on my website?
Embargoed news releases may be posted only to restricted-access websites for journalists. Do not post embargoed news releases to public websites. JAMA and JAMA Network studies cannot be posted on another website, but it is permissible to link to the studies from another website.
Q: Can I distribute my researcher’s JAMA or JAMA Network study to reporters?
Press officers are responsible for ensuring reporters uphold the JAMA Network embargo. Direct further questions to JAMA Network Media Relations. Journalists should be directed to JAMA Network Media Relations and/or the JAMA Media Center website for the study.
Q: What are the guidelines for distributing our own news releases?
Any news release or media advisory should have the study’s embargo time, date, and time zone at the top of the release or advisory and cite the correct journal name. Embargoed news releases should be distributed only to journalists. EurekAlert is a trusted partner and may be used.
Embargoed information cannot be posted to openly accessible websites, routed to electronic wire services such as PRNewswire, Ascribe or BusinessWire, or otherwise placed in the public domain. These and other services may be used when the embargo lifts.
Q: Does JAMA Media Relations need to approve my releases?
No.
Q: How can I best support authors from my institution or association?
JAMA Media Relations encourages press officers to help authors prepare for interviews by providing media training. Press officers may also by sign up for JAMA Media Center access and keep track of when studies are going under embargo and publishing.